Publications

Fan X, Liu E, Freudenreich O, Park JH, Liu D, Wang J, Yi Z, Goff DC, Henderson DC. 

Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia.  Schizophrenia Research, 2010; 118, 211-217.

Liu D, Fan X, Wang Y, Yang Z, Zhuo K, Song Z, Wu Y, Li C, Wang J, Xu Y.  

Deficient inhibition of return in chronic but not first-episode patients with schizophrenia.  Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2010; 34, 961-967.

Wang J, Liu E, Freudenreich O, Goff DC, Henderson DC, Fan X. 

Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia.  Schizophrenia Research, 2010; 124, 49-53.

Yi Z, Fan X, Wang J, Liu D, Freudenreich O, Goff DC, Henderson DC. 

Rosiglitazone and cognitive function in clozapine treated patients with schizophrenia: a pilot study.  Psychiatry Research, 2012; 200, 79-82.

Wang J, Fan X, Liu D, Yi Z, Freudenreich O, Goff DC, Henderson DC. 

Physical activity, food intake and metabolic abnormalities in patients with schizophrenia.  Schizophrenia Research, 2012; 140, 260-261.

Ou JJ, Xu Y, Chen HH, Fan X, Gao K, Wang J, Guo XF, Wu RR, Zhao JP. 

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.  Psychopharmacology (Berl), 2013; 225, 627-635.

Fan X, Song X. 

Non-steroidal anti-inflammatory drugs may reduce schizophrenia symptom severity in the short term when added to antipsychotics.  Evidence based Mental Health, 2013; 16, 10.

Zhuo K, Lu Y, Yang Z, Fan X, Song Z, Liao L, Ji C, Zhu D, Yu S, Yan C, Chan RCK, Goff DC, Xu Y, Liu D. 

Prospective memory performance in patients with drug-naïve, first-episode psychosis.  Schizophrenia Research, 2013; 143, 285-290.

Li J, Li X, Liu E, Song X, Copeland P, Freudenreich O, Goff DC, Henderson DC, Fan X. 

No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia.  Schizophrenia Research, 2013; 146, 40-45.

Song X, Fan X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L. 

Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight.  Schizophrenia Research, 2013; 150, 269-73.

Guo X, Li J, Wei Q, Fan X, Kennedy DN, Shen Y, Chen H, Zhao J. 

Duration of untreated psychosis is associated with temporal and occipitotemporal gray matter volume decrease in treatment naïve schizophrenia.  PLoS One, 2013; 8, e83679.

Song X, Li X, Gao J, Ding M, Zhao J, Li Y, Fan X, Lv L. 

APOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia.  PLoS One, 2014; 9, e93902.

Ding M, Song X, Zhao J, Gao J, Li X, Yang G, Wang X, Harrington A, Ziedonis D, Fan X, Lv L. 

Activation of Th17 cells in drug naïve, first episode schizophrenia.  Prog Neuropsychopharmacol Biol Psychiatry, 2014; 51, 78-82.

Guo X, Li J, Wang J, Fan X, Hu M, Shen Y, Chen H, Zhao J. 

Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naïve, first-episode patients with schizophrenia.  Schizophrenia Research, 2014; 152, 339-343.

Song X, Fan X, Li X, Zhang W, Gao J, Zhao J, Harrington A, Ziedonis D, Lv L. 

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first episode schizophrenia.  Psychopharmacology (Berlin), 2014; 231, 319-325.

Song X, Fan X, Zhang J, Zheng H, Li X, Pang L, Chen X, Zhang W, Ziedonis D, Lv L.

            Prolactin serum levels correlate with inflammatory status in drug naïve first episode schizophrenia. The World Journal of Biological Psychiatry, 2014; 15, 546-552. PMID: 24959913.

Sheng J, Li C, Wang J, Chiang C, Harrington A, Yi Z, Liu D, Fan X.

            Phenotypic characteristics in metabolically healthy but obese patients with schizophrenia. Psychiatry Research, 2014; 220, 71-75. PMID: 25086765.

Guo W, Hu M, Fan X, Liu F, W R, Chen J, Guo X, Xiao C, Quan M, Chen H, Zhai J, Zhao J.

            Decreased gray matter volume in the left middle temporal gyrus as a candidate biomarker for schizophrenia: a study of drug naive, first-episode schizophrenia patients and unaffected siblings. Schizophrenia Research, 2014; 159, 43-50. PMID: 25156295.

Song X, Fan X, Li X, Kennedy D, Hao Y, Quan M, Chen X, Gao J, Zhang W, Zhang J, Lv L.

            Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia. Schizophrenia Research, 2014; 159, 51-55. PMID: 25128453.

Song X, Pang L, Feng Y, Fan X, Li X, Zhang W, Gao J, Zhang J, Nemani K, Zhang H, Lv L.

            Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia. Behavior and Brain Function, 2014; 10, 35. doi: 10.1186/1744-9081-10-35. PMID: 25240858.

Song X, Quan M, Lv L, Li X, Pang L, Kennedy D, Hodge S, Harrington A, Ziedonis D, Fan X.

            Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF. Journal of Psychiatric Research, 2015; 60, 22-28. PMID: 25282282.

Tang Y, Li Y, Zhuo K, Wang Y, Liao L, Song Z, Li H, Fan X, Goff DC, Wang J, Xu Y, Liu D.

            Neural correlates of the preserved inhibition of return in schizophrenia. PLoS, 2015; 10:e0119521. doi: 10.1371/journal.pone.0119521. PMID: 25875486.

Du J, Quan M, Zhuang W, Zhong N, Jiang H, Kennedy D, Harrington A, Ziedonis D, Fan Z, Zhao M.

            Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behavioral Brain Research, 2015; 289, 78-83. PMID: 25920682.

Zhang Y, Zheng J, Fan X, Guo X, Guo W, Yang G, Chen H, Zhao J, Lv L.

            Dysfunctional resting-state connectivities of brain regions with structural deficits in drug naïve first episode schizophrenia adolescents. Schizophr Res. 2015. 168(1-2):353-9. PMID: 26281697.

Rajan S, Zalpuri I, Harrington A, Cimpeanu C, Song X, Fan X.

            Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia. Int Clin Psychopharmacol, 2016; 31, 51-56. PMID: 26550697.

Chiang M, Natarajan R, Fan X.

            Vitamin D in schizophrenia: a clinical review. Evidence Based Mental Health, 2016; 19, 6-9. PMID: 26767392.

Zeng B, Ardekani BA, Tang Y, Zhang T, Zhao S, Cui H, Fan X, Zhuo K, Li C, Xu Y, Goff DC, Wang J.

            Abnormal white matter microstructure in drug-naïve first episode schizophrenia patients before and after eight weeks of antipsychotic treatment. Schizophrenia Research, 2016. 172(1-3):1-8. PMID: 26852402.

Liu D, Ji C, Zhuo K, Song Z, Wang Y, Mei L, Zhu D, Xiang Q, Chen T, Yang Z, Zhu G, Wang Y, Cheung EF, Xiang YT, Fan X, Chan RC, Xu Y, Jiang K.

            Impaired cue identification and intention retrieval underlie prospective memory deficits in patients with first-episode schizophrenia. Aust N Z J Psychiatry, 2017; 51, 270-277. PMID: 27004487.

Luo Y, Yan C, Huang T, Fan M, Liu L, Zhao Z, Ni K, Jiang H, Huang X, Lu Z, Wu W, Zhang M, Fan X.

            Altered neural correlates of emotion associated pain processing in persistent somatoform pain disorder: an fMRI study. Pain Pract, 2016. doi: 10.1111/papr.12358. PMID: 27641732.

Pang L, Kennedy D, Wei Q, Lv L, Gao J, Li H, Quan M, Li X, Yang Y, Fan X, Song X.

            Decreased functional connectivity of insular cortex in drug-naïve first episode schizophrenia: in relation to symptom severity. PLoS One, 2017; 12(1):e0167242. doi: 10.1371/journal.pone.0167242. PMID: 28107346.

Wang Y, Tang W, Fan X, Zhang J, Geng D, Jiang K, Zhu D, Song Z, Xiao Z, Liu D.

            Resting-state functional connectivity changes within the default mode network and the salience antipsychotic treatment in early-phase schizophrenia. Neuropsychiatric Disease and Treatment, in press.

Zhao Z, Huang T, Tang C, Ni K, Pan X, Yan C, Fan X, Xu D, Luo Y.

            Altered resting-state intra- and inter-network functional connectivity in patients with persistent somatoform pain disorder. PLoS One, in press.